Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes
The prognosis for ovarian SCC remains unfavorable. The stage and age were prognostic predictors for survival. ICIs may be beneficial for patients with ovarian SCC, particularly those with a high TMB.
Authors
- Tianyu Zhang (ORCID: https://orcid.org/0000-0002-2627-9965)
- Jiaxin Yang (ORCID: https://orcid.org/0000-0003-4211-7832)
- Xiaohua Shi (ORCID: https://orcid.org/0000-0002-5007-5540)
- Sijian Li (ORCID: https://orcid.org/0000-0003-1578-0516)
- Jie Yang (ORCID: https://orcid.org/0000-0001-7661-2861)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3802/jgo.2025.36.e54
- Citations
- 3
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.09
Funders
- Chinese Academy of Medical Sciences
- Peking Union Medical College Hospital
- Peking Union Medical College